The Effects of Cimetidine (Tagamet®) on Renal Function in Patients with Renal Failure

Authors:

Abstract
Cimetidine has been administered during 7 days to 28 patients with different degrees of renal failure. Thirteen of these patients had a further week's treatment at least one month later. The daily dose of cimetidine was reduced in relation to pretrial values of creatinine clearance. There was a clear rise in serum creatinine all through the trial (22.3±2.6% at day 7) (pppp51Cr] EDTA clearance before, on day 3 of treatment and 3 days after treatment did not show any differences. No change was seen in serum β2‐microglobulin during the trial. The decrease in creatinine clearance during treatment with cimetidine is probably not caused by a reduction of glomerular filtration rate, but could be explained by competition by cimetidine for tubular secretion of creatinine. Treatment with cimetidine of patients with renal failure may invalidate measurements of serum creatinine and creatinine clearance as standard routine tests for glomerular filtration rate.

This publication has 21 references indexed in Scilit: